Sandbox Epi: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 29: | Line 29: | ||
** In females: _____ per 100,000 persons | ** In females: _____ per 100,000 persons | ||
Shown below is an image depicting the delay-adjusted incidence of | Shown below is an image depicting the delay-adjusted incidence and observed incidence of invasive esophageal cancer by gender and race in the United States between 1975 and 2011. These graphs are adapted from [[SEER]]: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. | ||
[Insert figure x.1 from the report] | [Insert figure x.1 from the report] | ||
Revision as of 14:24, 11 June 2014
Prevalence
- In the United States, the [age adjusted] prevalence of (insert disease name here) is _____ % in 2011.[1]
Incidence
- The delay-adjusted incidence of (insert disease name here) in 2011 was estimated to be _____ per 100,000 persons in the United States.[1]
- In 2011, the age-adjusted incidence of (insert disease name here) was _____ per 100,000 persons in the United States.[1]
Age
- While the overall age adjusted incidence of (insert disease name here) in the United States between 1975 and 2011 is _____ per 100,000, the age-adjusted incidence of (insert disease name here) by age category is:[1]
- Under 65 years: _____ per 100,000
- 65 and over: _____ per 100,000
Gender
- In the United States, the [age adjusted] prevalence of (insert disease name here) by gender in 2011 is:[1]
- In males: _____ %
- In females: _____ %
- In the United States, the delay-adjusted incidence of (insert disease name here) by gender in 2011 is:[1]
- In males: _____ per 100,000 persons
- In females: _____ per 100,000 persons
- In the United States, the age-adjusted incidence of (insert disease name here) by gender on 2011 is:[1]
- In males: _____ per 100,000 persons
- In females: _____ per 100,000 persons
Shown below is an image depicting the delay-adjusted incidence and observed incidence of invasive esophageal cancer by gender and race in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.
[Insert figure x.1 from the report]
Race
- Shown below is a table depicting the [age adjusted] prevalence of (insert disease name here) by race in 2011 in the United States.[1]
| All Races | White | Black | Asian/Pacific Islander | American Indian/Alaska Native | Hispanic | |
| Age-adjusted prevalence |
- In the United States, the race that is most susceptible to developing this disease/condition, is the ____ race.[1]
Shown below is an image depicting the incidence of (insert disease name here) by race in the United States between 1975 and 2011.[1]
[Insert figure x.2 from the report]
Percent Distribution of (insert disease name here) by Histology
- Among patients with histologically confirmed cases of (insert disease name here), the percent distribution of the types of the disease between 2004 and 2010 in the United States are:[1]
- Type X: _____ %
- Type Y: _____ %
- Type Z: _____ %
5 Year Survival
- Between (insert age here) and (insert age here), the 5 year relative survival of patients with (insert disease name here) was _____ %.[1]
- When stratified by age, the 5 year relative survival of patients with (insert disease name here) was ____ % and ____ % for patients <65 and ≥ 65 years of age respectively.[1]
- The survival of patients with (insert disease name here) varies with the stage of the disease. Shown below is a table depicting the 5 year relative survival by the stage of (insert disease name here):[1]
| Stage | 5 year relative survival (%), (Insert range of years here) |
| All stages | |
| Localized | |
| Regional | |
| Distant | |
| Unstaged |
Shown below is an image depicting 5 year conditional relative survival (probability of surviving in the next 5 years given the cohort has already survived 0, 1, 3 years) by stage at diagnosis according to SEER.[1]
[Insert figure x.5 here]
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.